Entrepreneur

Biotech Stock Roundup: REGN Gives Study Update, INCY Wins Drug Approval & More

Regulatory and pipeline updates from Regeneron (REGN) and Incyte (INCY), among others, have been in focus in the biotech industry over the past week.